Security key
03168L105
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)
CUSIP: 03168L105
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Class A Common Stock, par value $0.01
- Shares outstanding
- 313,041,907
- Total 13F shares
- 141,656,835
- Share change
- +6,925,610
- Total reported value
- $1,146,033,099
- Put/Call ratio
- 25%
- Price per share
- $8.09
- Number of holders
- 237
- Value change
- +$54,531,142
- Number of buys
- 138
- Number of sells
- 88
Report period
Q2 2025
Institutions
237
Top holders
10
AMRX full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Amneal Pharmaceuticals, Inc. SEC filings
Amneal Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03168L105
Recent filing periods:
Top shareholders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Tushar Bhikhubhai Patel |
3/4/5
13D/G
|
10%+ Owner · Patel Tushar Bhikhubhai |
16%
from 13D/G
|
48,578,209
|
$405,628,045 | — | 14 Mar 2025 | |
| Akram Mahesh |
13D/G
|
— |
6.6%
|
20,558,759
|
$153,779,517 | $0 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
5%
from 13D/G
|
15,762,727
|
$132,091,652 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4%
|
12,587,778
|
$105,485,581 | — | 31 Mar 2025 | |
| TPG GP A, LLC |
13F
3/4/5
|
Company · Former 10% Owner |
3.9%
|
12,328,767
|
$103,315,067 | — | 31 Mar 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
3.4%
|
10,735,977
|
$89,967,487 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.4%
|
7,492,029
|
$62,783,203 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.6%
|
5,103,156
|
$42,761,001 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
3,825,411
|
$32,063,954 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.2%
|
3,808,561
|
$31,915,741 | — | 31 Mar 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
1.2%
|
3,735,083
|
$31,398,180 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
3,690,354
|
$30,925,167 | — | 31 Mar 2025 | |
| BlackBarn Capital Partners LP |
13F
|
Company |
0.92%
|
2,881,654
|
$24,148,261 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.83%
|
2,598,294
|
$21,759,000 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.75%
|
2,336,628
|
$19,580,943 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.73%
|
2,272,713
|
$19,045,336 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.67%
|
2,087,398
|
$17,492,395 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.58%
|
1,812,375
|
$15,187,703 | — | 31 Mar 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.57%
|
1,793,453
|
$15,029,136 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.56%
|
1,767,594
|
$14,812,435 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.56%
|
1,765,965
|
$14,798,787 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
1,708,627
|
$14,318,294 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.53%
|
1,663,336
|
$13,938,756 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.52%
|
1,621,001
|
$13,583,988 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.48%
|
1,504,095
|
$12,604,316 | — | 31 Mar 2025 | |
| HENNESSY ADVISORS INC |
13F
|
Company |
0.48%
|
1,499,400
|
$12,564,972 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.44%
|
1,376,656
|
$11,536,377 | — | 31 Mar 2025 | |
| Phocas Financial Corp. |
13F
|
Company |
0.4%
|
1,259,378
|
$10,553,588 | — | 31 Mar 2025 | |
| TUCKER ASSET MANAGEMENT LLC |
13F
|
Company |
0.35%
|
1,111,064
|
$9,310,716 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.35%
|
1,091,690
|
$9,148,361 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.3%
|
937,189
|
$7,853,644 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.26%
|
819,736
|
$6,869,388 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.24%
|
745,475
|
$6,247,081 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.23%
|
719,080
|
$6,025,890 | — | 31 Mar 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.22%
|
684,116
|
$5,732,892 | — | 31 Mar 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.2%
|
630,351
|
$5,282,341 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.2%
|
624,700
|
$5,234,986 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
598,389
|
$5,014,504 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.19%
|
596,502
|
$4,998,769 | — | 31 Mar 2025 | |
| Numerai GP LLC |
13F
|
Company |
0.19%
|
596,131
|
$4,995,578 | — | 31 Mar 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.18%
|
560,783
|
$4,699,000 | — | 31 Mar 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.18%
|
558,842
|
$4,683,096 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.17%
|
537,352
|
$4,503,009 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.17%
|
527,685
|
$4,422,000 | — | 31 Mar 2025 | |
| DARK FOREST CAPITAL MANAGEMENT LP |
13F
|
Company |
0.16%
|
499,707
|
$4,187,545 | — | 31 Mar 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.15%
|
483,804
|
$4,034,647 | — | 31 Mar 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.15%
|
459,444
|
$3,850,141 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.14%
|
446,000
|
$3,737,480 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
436,797
|
$3,660,359 | — | 31 Mar 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.13%
|
400,294
|
$3,354,463 | — | 31 Mar 2025 |
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2025
As of 30 Jun 2025,
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by
237 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
141,656,835 shares.
The largest 10 holders included
VANGUARD GROUP INC, TPG GP A, LLC, BlackRock, Inc., Rubric Capital Management LP, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, MILLENNIUM MANAGEMENT LLC, Nantahala Capital Management, LLC, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
240
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
232
Q2 2025 holders
237
Holder diff
5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.